Cancer metastasis driven by PITPNM3 has been reported in breast cancer (BRCA),[3, 4] hepatocellular carcinoma,[5] and pancreatic ductal carcinoma.[6] However, oncogenic role of PITPNM3 is undetermined in pan‐cancer. Here, PITPNM3 is linked to hepatocellular carcinoma.